Integrating Genomic Data into the Clinical Workflow | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Integrating Genomic Data into the Clinical Workflow

April 16, 2015
by Kayt Sukel
| Reprints
Click To View Gallery

The era of clinical genomics is upon us.  How will technologies like whole genome sequencing, and the exobytes of data these laboratory processes create, transform the face of clinical care?  These are the questions that Mark Blatt, WW Medical Director at Intel, and James Lowey, Vice President of Technology at TGen, attempted to answer yesterday afternoon in their HIMSS15 E-Session, "Using Genomic Data to Make a Difference in Clinical Care."

Dr. Blatt started the session with a video about Shelby, a young girl with a rare genetic disorder.  Shelby was wheelchair bound and no one was sure what was wrong with her--until her doctors were able to perform the sequencing to identify her genetic defect.  Once found, doctors were able to treat Shelby.  And she is now wheelchair-free.  Her story is a wonderful example of how whole genome sequencing can inform the diagnosis and treatment of both common and rare diseases.

Blatt discussed how whole genome sequencing (WGS) has moved from the bench to the bedside.  And he addressed some of the technological issues involved with using it for clinical decision support.  For example, WGS processes create a phenomenal amount of data.  "Storing these amounts of data is a problem," he said,  "Moving this data is a problem.  Genomic data consumes a tremendous amount of resources.  It is the epitome of big data." 

And those are problems we need to address--now rather than later.  Because even today, WGS is being used more and more.  And as WGS is expected to one day only cost $100 and take less than an hour to process, it is going to quickly become a viable lab test for everyday patients.

James Lowey took over the presentation to discuss some of these technical issues--and how TGen is helping to move genomics from bench to bedside.  He explained advancements in computing infrastructure and real-time analytics of both structured and unstructured data.  And he discussed how these tools, as well as practical changes in both research and clinical workflows can make personalized medicine, through the use of WGS, a reality.

This HIMSS15 E-Session, "Using Genomic Data to Make a Difference in Clinical Care," is available on demand on HIMSS15 Online. 

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Healthcare Execs Anticipate High Cost Returns from Predictive Analytics Use

Healthcare executives are dedicating budget to predictive analytics, and are forecasting significant cost savings in return, according to new research from the Illinois-based Society of Actuaries.

Adam Boehler Tapped by Azar to Serve as Senior Value-Based Care Advisor

Adam Boehler, currently director of CMMI, has also been named the senior advisor for value-based transformation and innovation, HHS Secretary Alex Azar announced.

Vivli Launches Clinical Research Data-Sharing Platform

On July 19 a new global data-sharing and analytics platform called Vivli was unveiled. The nonprofit group’s mission is to promote, coordinate and facilitate scientific sharing and reuse of clinical research data.

Survey: More Effective IT Needed to Improve Patient Safety

In a Health Catalyst survey, physicians, nurses and healthcare executives said ineffective information technology, and the lack of real-time warnings for possible harm events, are key obstacles to achieving their organizations' patient safety goals.

Physicians Still Reluctant to Embrace Virtual Tech, Survey Finds

While consumers and physicians agree that virtual healthcare holds great promise for transforming care delivery, physicians still remain reluctant to embrace the technologies, according to a new Deloitte Center for Health Solutions survey.

Geisinger, AstraZeneca Partner on Asthma App Suite

Geisinger has partnered with pharmaceutical company AstraZeneca to create a suite of products that integrate into the electronic health record and engage asthma patients and their providers in co-managing the disease.